期刊文献+

hPARP1酶在杆状病毒/昆虫细胞中的高表达及快速纯化 被引量:3

Expression and purification of hPARP1 by baculovirus system
原文传递
导出
摘要 PARP1是动物细胞内的一种重要的DNA修复酶。近几年PARP1作为新型的抗癌靶点,受到广泛的关注。为了获得高活性的PARP1,首先将hPARP1基因克隆到载体pFastBacTM1中,构建转移载体pFast-hPARP1;然后转化大肠杆菌Escherichia coli DH10Bac感受态细胞中。其次,通过位点特异性转座,将hPARP1基因整合到Bacmid穿梭载体中,构建表达质粒Bacmid-hPARP1。最后,通过脂质体将表达质粒转染Sf9昆虫细胞。Western blotting和酶活测定法对hPARP1的表达和活性进行分析。采用3-氨基苯甲酰胺亲和层析柱对收获的昆虫细胞中表达的hPARP1酶进行纯化。Western blotting结果表明在昆虫细胞中hPARP1酶表达成功。经3-氨基苯甲酰胺亲和层析柱纯化后,Sf9昆虫细胞表达出的hPARP1酶的比活由0.051 nmol/(minμg)提高到了1.988 nmol/(min.μg),而且每100 mL的细胞中能够收获约3.2 mg酶。实验结果为PARP1大规模生产和应用提供了可参考利用的技术。 PARP1 is an important part of DNA repair machinery.In recent years,PARP1 as novel anti-cancer therapeutic target has been broadly explored.In this study,we expressed hPARP1 enzyme in the baculovirus system and tested its activity.We inserted hPARP1 gene into the pFastBac^ TM 1,a baculovirus transfer vector and then transformed it into DH10Bac containing a shuttle vector of Bacmid.After co-transfecting the recombinant plasmid into Sf9 insect cells,the expressed hPARP1 was purified by 3-aminobezamide affinity chromatography.The expression of hPARP1 was visualized by SDS-PAGE and Western blotting;the activity of expressed and purified hPARP1 was confirmed by the reaction of consumption of NAD + by hPARP1 in vitro.After the purification by 3-aminobezamide affinity column,3.2 mg protein was obtained and its specific activity was 1.988 nmol/(min μg).
出处 《生物工程学报》 CAS CSCD 北大核心 2013年第7期998-1005,共8页 Chinese Journal of Biotechnology
关键词 hPARP1 杆状病毒 表达 纯化 hPARP1 baculovirus system expression affinity purification
  • 相关文献

参考文献20

  • 1Jagtap P,Szabo C. Poly (ADP-ribose)polymeraseand the therapeutic effects of its inhibitors. Nat RevDrug Discov,2005,4(5):421-440.
  • 2Aguilar-Quesada R,Munoz-Gamez J,Martin-OlivaD,et al. Modulation of transcription by PARP-1:consequences in carcinogenesis and inflammation.Curr Med Chem,2007(11),14:1179-1187.
  • 3Bryant HE,Schultz N,Thomas HD,et al. Specifickilling of BRCA2-deficient tumours with inhibitorsof poly (ADP-ribose)polymerase. Nature,2005,434(7035):913-917.
  • 4Beneke S,Burkle A. Poly (ADP-Ribosyl)ation andaging. Exp Gerontol,2004,39(11):234-241.
  • 5Langelier MF,Planck JL,Roy S,et al. Structuralbasis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP1. Science,2012,336(6082):728-732.
  • 6Burtscher HJ,Auer B,Klocker H,et al. Isolation ofADP-ribosyltransferasebyaffinitychromatography. Anal Biochem,1986,152(2):285-290.
  • 7Kaiser P,Auer B,Schweiger M. Inhibition of cellproliferation in Saccharomyces cerevisiae byexpressionofhumanNAD+ADP-ribosyltransferase requires the DNA bindingdomain ("zinc fingers"). Mol Gen Genet,1992,232(2):231-239.
  • 8Fritz G,Auer B,Kaina B. Effect of transfection ofhuman poly (ADP-ribose)polymerase in Chinesehamster cells on mutagen resistance. Mutat Res,1994,308(2):127-133.
  • 9Giner H,Simonin F,de Murcia G,et al.Overproduction and large-scale purification of thehuman poly (ADP-ribose)polymerase using abaculovirus expression system. Gene,1992,114(2):279-283.
  • 10Putt KS,Hergenrother PJ. An enzymatic assay forpoly (ADP-ribose)polymerase-1 (PARP-1)via thechemical quantitation of NAD+:application to thehigh-throughput screening of small molecules aspotential inhibitors. Anal Biochem,2004,326(1):78-86.

二级参考文献45

  • 1韩光亮,尚念勇,杜冠华.酪氨酸蛋白激酶抑制剂的高通量筛选模型[J].中国药理学通报,2005,21(5):628-631. 被引量:17
  • 2刁勇,许瑞安.细胞生物技术实验指南.北京:化学工业出版社,2008:221-261.
  • 3Xu R, Sun X, Tse LY, et al. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology, 2003, 37(6): 1451-1460.
  • 4Shi J, Zheng D, Liu Y, et al. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res, 2005, 65(5): 1687-1692.
  • 5Eberling JL, Jagust WJ, Christine CW, et al. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease, hAADC. Neurology, 2008, 70(21): 1980-1983.
  • 6Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocularsubretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther, 2008, 19(10): 979-990.
  • 7Urabe M, Ding C, Kotin RM, et al. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther, 2002, 13(16): 1935-1943.
  • 8Muzyczka N. Use of adeno-associated virus as a general transduction, vector for mammalian cells. Curr Top MicrobiolImmunol, 1992, 158: 97-129.
  • 9Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol, 1998, 72(3): 2224-2232.
  • 10Xu R, Janson, CG, Mastakov M, et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther, 2001, 8(17): 1323-1332.

共引文献13

同被引文献40

  • 1柳军,张陆勇.聚腺苷二磷酸核糖聚合酶-1抑制剂高通量筛选模型[J].中国药理学通报,2007,23(1):124-127. 被引量:7
  • 2Woodhouse B C,Dianov G L.Poly ADP-ribose polymerase-1:An international molecule of mystery[J].DNA Repair(Amst),2008,7(7):1077-1086.
  • 3Jagtap P,Szabo C.Poly(ADP-ribose)polymerase and the therapeutic effects of its inhibitors[J].Nat Rev Drug Discov,2005,4(5):421-440.
  • 4Abd Elmageed Z Y,Naura A S,Errami Y,et al.The poly(ADP-ribose)polymerases(PARPs):New roles in intracellular transport[J].Cell Signal,2012,24(1):1-8.
  • 5Peralta-Leal A,Rodriguez-Vargas J M,Aguilar-Quesada R,et al.PARP inhibitors:New partners in the therapy of cancer and inflammatory diseases[J].Free Radic Biol Med,2009,47(1):13-26.
  • 6Lee J M,Ledermann J A,Kohn E C.PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-Iike malignancies[J].Ann 0ncol,2014,25(1):32-40.
  • 7Plummer R,Jones C,Middleton M,et al.Phase I study of the poly(ADP-ribose)polymerase inhibitor,AG014699,in combination with temozolomide in patients with advanced solid tumors[J].Clin Cancer Res,2008,14(23):7917-7923.
  • 8Ferraris D V.Evolution of poly(ADP-ribose)polymerase-1(PARP-1)inhibitors:From concept to clinic[J].J Med Chem,2010,53(12):4561-4584.
  • 9Putt K S,Hergenrother P J.An enzymatic assay for poly(ADP-ribose)polymerase-1(PARP-1)via the chemical quantitation of NAD(+):Application to the high-throughput screening of small molecules as potential inhibitors[J].Anal Biochem,2004,326(1):78-86.
  • 10Geraets L,Moonen H J,Wouters E F,et al.Caffeine metabolites are inhibitors pf the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations[J].Biochem Pharmacol,2006,72(7):902-910.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部